1932

Abstract

Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in 2002, TAVR has made remarkable progress in the past decade with completion of major randomized clinical trials, multiple observational registries, and evolution of several new devices. This article is a brief introductory overview of the TAVR procedure, devices, trials and registries, and newer developments in the field.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-010813-102251
2014-01-14
2024-06-23
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-med-010813-102251
Loading
/content/journals/10.1146/annurev-med-010813-102251
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error